⬡ Sandbox preview — runs on mock referrals, no backend, no real patient data. Manas AI reads & drafts are pre-baked sample outputs so you can walk the full flow. The live console calls the deployed backend instead.
PROPHYSIO
Cardiac · Manas AI · DEMO
Select a referral from the queue to begin.
Discharge Summary
Precision viewer — scroll to zoom, drag to pan. Adjust brightness/contrast/invert to read faint photocopies. Signed URL expires in 15 min; reload referral if it blanks.
Bright Contrast
Manas AI Read
Extraction only — Manas AI pulls structured data from the summary. It makes no safety judgments. Verify every field against the document in step ①.
Rule-Based Safety Screen
AACVPR contraindications & risk stratification. Items marked AUTO-FLAG were tripped by extracted data — they are rules, not AI opinions. You must confirm or clear each one yourself.
⛔ One or more absolute contraindications confirmed — do NOT proceed to programme. Refer back to treating cardiologist.
Programme Builder
Manas AI drafts a 6-week Phase II skeleton from your confirmed screen. Every field is editable — the programme is yours, not the AI's. Open 🔬 Research alongside while you refine.
Wearable Monitoring
Set training zones for session monitoring. Karvonen (heart-rate reserve) calculator below — if the patient is on a beta-blocker, the console defaults to RPE-led intensity and flags HR zones as advisory only.
β-blocker on med list — HR zones are advisory. Prescribe by RPE 11–13 and symptoms; use the wearable for trend & arrhythmia awareness, not targets.
Works in Chrome/Edge with standard BLE heart-rate devices. Apple Watch streams via gateway apps — bundling decision per the wearable roadmap.
Sign-off & Send
Hard gates below are enforced server-side as well. The send message goes to the patient's WhatsApp with the payment link. Therapy is activated on payment.
I have personally reviewed the discharge summary, verified the Manas AI extraction, completed the safety screen, and edited the programme. This is my clinical prescription.
Pratima Nagpal (Medical Director) has reviewed and signed off this programme. Non-negotiable gate — the send button stays locked without it.
🔬 Research · PubMed
Search PubMed without leaving the build. Results open in a new tab.
📕 Gold Standard Quick Reference
AACVPR Risk Stratification (summary)
Low: EF ≥50%, no complex arrhythmias, uncomplicated procedure, no ischemia/abnormal hemodynamics with exertion, functional capacity ≥7 METs, no depression.
Moderate: EF 40–49%, signs/symptoms at ≥7 METs, mild-moderate silent ischemia.
High: EF <40%, survivor of cardiac arrest, complex arrhythmias, complicated MI/procedure, abnormal hemodynamics with exertion, ischemia at low workload, clinically significant depression.